Table 1 Characteristics of the study population
Total sample N = 426 | |
|---|---|
Age | 64 (58–70)* |
Age (categories) | |
40–50 | 20 (4.7%) |
51–60 | 127 (29.8%) |
61–70 | 188 (44.1%) |
71–80 | 75 (17.6%) |
> 80 | 16 (3.8%) |
BMIa | 28 (25–30)* |
BMI (categories) | |
< 25 | 134 (31.5%) |
25–30 | 234 (54.9%) |
> 30 | 58 (13.6%) |
Marital status | |
Married | 424 (99.5%) |
Not married | 2 (0.5%) |
Smoking | |
Yes | 254 (59.6%) |
No | 172 (40.4%) |
IPSSb | 19 (14–24)* |
IPSS severity | |
Mild | 52 (12.2%) |
Moderate | 174 (40.8%) |
Severe | 200 (46.9%) |
Blood pressure: SBPc ≥130 mmHg or/and DBPd ≥ 85 mmHg or on antihypertensive drug treatment | |
Yes | 263 (61.7%) |
No | 163 (38.3%) |
Fasting blood glucose: ≥ 110 mg/dl or on drug treatment for elevated glucose | |
Yes | 208 (48.8%) |
No | 218 (51.2%) |
Waist circumference: ≥ 102 cm | |
Yes | 129 (30.3%) |
No | 297 (69.7%) |
HDLe: ≤ 40 mg/dl | |
Yes | 280 (65.7%) |
No | 146 (34.3%) |
Triglycerides: ≥ 150 mg/dl or on drug treatment for elevated triglyceride | |
Yes | 271 (63.6%) |
No | 155 (36.4%) |
Metabolic syndrome | |
Yes | 197 (46.2%) |
No | 229 (53.8%) |
Prostate Volume | 40 (30–55)* |